| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $37.79 ▼ -4.33% | Yesterday | $39.50 • 0.00% | Tomorrow's TG Therapeutics Inc. Common Stock (TGTX) setup is anchored to $39.50 and targets $37.79 (-4.33%). The near-term read is downside; watch $41.40 / $37.60 because daily realized volatility is about 7.62%. |
Tomorrow's TG Therapeutics Inc. Common Stock (TGTX) setup is anchored to $39.50 and targets $37.79 (-4.33%). The near-term read is downside; watch $41.40 / $37.60 because daily realized volatility is about 7.62%. | ||||
| Week | $36.20 ▼ -8.35% | Last Week | $39.50 • 0.00% | The 7-day TG Therapeutics Inc. Common Stock model moves from $39.50 to $36.20 (-8.35%). It gives downside momentum context for this stock, so breaks around $41.40 / $37.60 matter more than a single tick. |
The 7-day TG Therapeutics Inc. Common Stock model moves from $39.50 to $36.20 (-8.35%). It gives downside momentum context for this stock, so breaks around $41.40 / $37.60 matter more than a single tick. | ||||
| Month | $34.71 ▼ -12.13% | Last Month | $39.50 • 0.00% | The 1-month TG Therapeutics Inc. Common Stock target is $34.71 (-12.13%), compared with the live reference near $39.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month TG Therapeutics Inc. Common Stock target is $34.71 (-12.13%), compared with the live reference near $39.50. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $32.83 ▼ -16.89% | Last Year | $39.50 • 0.00% | The 1-year TG Therapeutics Inc. Common Stock scenario points to $32.83 (-16.89%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year TG Therapeutics Inc. Common Stock scenario points to $32.83 (-16.89%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $28.61 ▼ -27.57% | 5 Years Ago | $39.50 • 0.00% | The 5-year TG Therapeutics Inc. Common Stock view is $28.61 (-27.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year TG Therapeutics Inc. Common Stock view is $28.61 (-27.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 49.3 | Neutral |
| MACD | -0.10 | Bearish |
| SMA 50 | $37.87 | Mid |
| SMA 200 | $38.41 | Mid |
| EMA 20 | $37.80 | Mid |
| Opening Price | $39.50 | Start Date | 2021-05-17 |
| Day Range | $37.54 – $41.46 | Market Cap | $5.79B |
| Monthly Range | $31.54 – $43.11 | 24h Volume | n/a |
| 90D Range | $30.48 – $44.32 | Circulating | n/a |
| 52W Range | $27.58 – $45.82 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.